# clm_D0F44FB1629D

subject: AbbVie (/record/abbvie.md)  
predicate: cash_and_equivalents  
value: 6,711,000,000 United States dollar  
valid_from: 2023-03-31  
valid_to: 2023-06-30  
published: 2023-05-05  
recorded: 2026-11-08  
confidence: 0.95  
status: superseded  
assertable: true  
superseded_by: clm_F77382A19536  
last_updated: 2026-11-08  
cite: AsOf. "AbbVie cash and equivalents: 6,711,000,000 United States dollar", as of 2023-03-31 (until 2023-06-30). Claim clm_D0F44FB1629D, https://asof.is/claim/clm_D0F44FB1629D, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/1551152/000155115223000023/0001551152-23-000023-index.htm.  
checked: 2026-11-08 · parsed from the SEC filing  
parsed from: us-gaap:CashAndCashEquivalentsAtCarryingValue in 10-Q Q1 FY2023, filed 2023-05-05  

## Sources

- https://www.sec.gov/Archives/edgar/data/1551152/000155115223000023/0001551152-23-000023-index.htm (primary, SEC EDGAR 10-Q Q1 FY2023, published 2023-05-05)

## Supersedes

- [AbbVie](/record/abbvie.md) | cash_and_equivalents | 9,201,000,000 United States dollar | valid 2022-12-31 to 2023-03-31 | conf 0.95 | superseded | superseded_by [clm_D0F44FB1629D](/claim/clm_D0F44FB1629D.md) | [clm_9196480FD2FF](/claim/clm_9196480FD2FF.md)

---

AsOf is a temporal fact ledger: a structured, dated, sourced record of what is true and what changed, built for AI retrieval.